Candriam S.C.A. Alnylam Pharmaceuticals, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 351,668 shares of ALNY stock, worth $90.7 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

351,668

Previous 351,228 0.13%

Holding current value

$90.7 Million

Previous $85.3 Million 13.34%

% of portfolio

0.57%

Previous 0.52%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $102,876 - $126,284	440 Added 0.13%	351,668 $96.7 Million
Q2 2024 Aug 05, 2024	BUY	$143.31 - $247.0 $4.92 Million - $8.48 Million	34,330 Added 10.83%	351,228 $85.3 Million
Q1 2024 May 03, 2024	BUY	$146.51 - $198.2 $9.74 Million - $13.2 Million	66,514 Added 26.56%	316,898 $47.4 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $11.9 Million - $15.4 Million	-78,510 Reduced 23.87%	250,384 $47.9 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $1.71 Million - $2.12 Million	10,000 Added 3.14%	328,894 $58.2 Million
Q2 2023 Aug 08, 2023	SELL	$185.01 - $212.05 $1.74 Million - $1.99 Million	-9,397 Reduced 2.86%	318,894 $60.6 Million
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $1.42 Million - $1.84 Million	7,796 Added 2.43%	328,291 $65.8 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $6.04 Million - $7.86 Million	-32,553 Reduced 9.22%	320,495 $76.2 Million
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $1.36 Million - $2.28 Million	9,835 Added 2.87%	353,048 $70.7 Million
Q2 2022 Aug 03, 2022	BUY	$120.42 - $169.29 $4.76 Million - $6.7 Million	39,560 Added 13.03%	343,213 $50.1 Million
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $8.02 Million - $11 Million	63,082 Added 26.22%	303,653 $49.6 Million
Q4 2021 Feb 10, 2022	BUY	$159.56 - $209.29 $17.2 Million - $22.5 Million	107,492 Added 80.77%	240,571 $40.8 Million
Q3 2021 Nov 09, 2021	SELL	$169.75 - $207.73 $7.09 Million - $8.67 Million	-41,743 Reduced 23.88%	133,079 $25.1 Million
Q2 2021 Jul 20, 2021	BUY	$128.63 - $176.89 $1.58 Million - $2.17 Million	12,264 Added 7.54%	174,822 $29.6 Million
Q4 2020 Jan 22, 2021	SELL	$122.97 - $147.0 $620,014 - $741,174	-5,042 Reduced 3.01%	162,558 $21.1 Million
Q2 2020 Jul 23, 2020	SELL	$104.21 - $156.44 $2.41 Million - $3.62 Million	-23,132 Reduced 12.13%	167,600 $24.8 Million
Q4 2019 Jan 21, 2020	BUY	$74.51 - $124.23 $49,102 - $81,867	659 Added 0.35%	190,732 $22,000
Q3 2019 Oct 21, 2019	SELL	$70.9 - $87.82 $13.6 Million - $16.8 Million	-191,651 Reduced 50.21%	190,073 $15,000
Q2 2019 Aug 01, 2019	BUY	$65.86 - $92.79 $6.39 Million - $9 Million	97,023 Added 34.08%	381,724 $27.6 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $3.35 Million - $4.72 Million	53,491 Added 23.14%	284,701 $20.8 Million
Q3 2018 Nov 07, 2018	BUY	$87.52 - $122.67 $9.85 Million - $13.8 Million	112,500 Added 94.77%	231,210 $20.2 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $2.08 Million - $2.53 Million	23,500 Added 24.68%	118,710 $11.7 Million
Q1 2018 May 09, 2018	BUY	$115.92 - $148.54 $11,823 - $15,151	102 Added 0.11%	95,210 $11.3 Million
Q4 2017 Feb 07, 2018	SELL	$114.49 - $139.98 $2.85 Million - $3.48 Million	-24,892 Reduced 20.74%	95,108 $12.1 Million
Q3 2017 Nov 03, 2017	BUY	$72.53 - $118.27 $8.7 Million - $14.2 Million	120,000	120,000 $14.1 Million

Others Institutions Holding ALNY

# of Institutions

639

Shares Held

108M

Call Options Held

1.15M

Put Options Held

1.07M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account